Your Comments On...

Biotechs Race for New Vaccine

Developing a next-generation anthrax vaccine is not for the weak of heart -- or wallet. Just two years ago, a revoked federal contract for a purportedly new and improved vaccine left a California biotech in ruins.
 - 

By Kendra Marr